232 related articles for article (PubMed ID: 7905013)
21. Symptomatic and hemodynamic recovery following dobutamine stress echo: benefit of low-dose esmolol administration.
Abdullah EE; Pollick C
Int J Card Imaging; 1997 Feb; 13(1):53-7. PubMed ID: 9080239
[TBL] [Abstract][Full Text] [Related]
22. The pharmacokinetics of esmolol in pediatric subjects with supraventricular arrhythmias.
Adamson PC; Rhodes LA; Saul JP; Dick M; Epstein MR; Moate P; Boston R; Schreiner MS
Pediatr Cardiol; 2006; 27(4):420-7. PubMed ID: 16835806
[TBL] [Abstract][Full Text] [Related]
23. Safety of esmolol in patients with acute myocardial infarction treated with thrombolytic therapy who had relative contraindications to beta-blocker therapy.
Mooss AN; Hilleman DE; Mohiuddin SM; Hunter CB
Ann Pharmacother; 1994 Jun; 28(6):701-3. PubMed ID: 7919552
[TBL] [Abstract][Full Text] [Related]
24. Use of esmolol during anesthesia to treat tachycardia and hypertension.
Gold MI; Sacks DJ; Grosnoff DB; Herrington C; Skillman CA
Anesth Analg; 1989 Feb; 68(2):101-4. PubMed ID: 2563314
[TBL] [Abstract][Full Text] [Related]
25. Comparative effects of esmolol and verapamil in a model of a supraventricular tachydysrhythmia.
Tuman KJ; McCarthy RJ; Wong CA; Labarge AM; Spiess BD; Ivankovich AD
Anesthesiology; 1990 Sep; 73(3):467-73. PubMed ID: 1975485
[TBL] [Abstract][Full Text] [Related]
26. Intravenous esmolol is well tolerated in elderly patients with heart failure in the early phase of non-ST elevation myocardial infarction.
Koutouzis M; Nikolidakis S; Grigoriadis A; Koutsogeorgis D; Kyriakides ZS
Drugs Aging; 2006; 23(8):673-80. PubMed ID: 16964989
[TBL] [Abstract][Full Text] [Related]
27. Use of an ultrashort-acting beta-receptor blocker (esmolol) in patients with acute myocardial ischemia and relative contraindications to beta-blockade therapy.
Kirshenbaum JM; Kloner RF; McGowan N; Antman EM
J Am Coll Cardiol; 1988 Sep; 12(3):773-80. PubMed ID: 2900259
[TBL] [Abstract][Full Text] [Related]
28. Esmolol reduces autonomic hypersensitivity and length of seizures induced by electroconvulsive therapy.
Howie MB; Black HA; Zvara D; McSweeney TD; Martin DJ; Coffman JA
Anesth Analg; 1990 Oct; 71(4):384-8. PubMed ID: 1975995
[TBL] [Abstract][Full Text] [Related]
29. Esmolol: a titratable short-acting intravenous beta blocker for acute critical care settings.
Turlapaty P; Laddu A; Murthy VS; Singh B; Lee R
Am Heart J; 1987 Oct; 114(4 Pt 1):866-85. PubMed ID: 2889341
[TBL] [Abstract][Full Text] [Related]
30. Use of esmolol in hypertension after cardiac surgery.
Gray RJ; Bateman TM; Czer LS; Conklin C; Matloff JM
Am J Cardiol; 1985 Oct; 56(11):49F-56F. PubMed ID: 2864849
[TBL] [Abstract][Full Text] [Related]
31. Esmolol for potentiation of nitroprusside-induced hypotension: impact on the cardiovascular, adrenergic, and renin-angiotensin systems in man.
Edmondson R; Del Valle O; Shah N; Wong G; Dwyer D; Matarazzo D; Thorne A; Coffey C; Bedford R
Anesth Analg; 1989 Aug; 69(2):202-6. PubMed ID: 2569849
[TBL] [Abstract][Full Text] [Related]
32. Treatment of caffeine toxicity with esmolol.
Price KR; Fligner DJ
Ann Emerg Med; 1990 Jan; 19(1):44-6. PubMed ID: 1688693
[TBL] [Abstract][Full Text] [Related]
33. Dupont critical care lecture: role of ultrashort-acting beta-blockers in the perioperative period.
Kaplan JA
J Cardiothorac Anesth; 1988 Oct; 2(5):683-91. PubMed ID: 17171962
[TBL] [Abstract][Full Text] [Related]
34. [Successful control of rapid heart rate with atrial flutter by intravenous administration of esmolol in a patient after total correction of the tetralogy of Fallot].
Masamune T; Suzuki S; Nonaka A; Imamura M; Abe F
Masui; 2004 Aug; 53(8):918-20. PubMed ID: 15446684
[TBL] [Abstract][Full Text] [Related]
35. [The hemodynamic effects of a treatment with beta-receptor blockers during coronary surgery. A comparison between acebutolol and esmolol].
Kling D; Boldt J; Zickmann B; Dapper F; Hempelmann G
Anaesthesist; 1990 May; 39(5):264-8. PubMed ID: 1972611
[TBL] [Abstract][Full Text] [Related]
36. Prophylactic esmolol infusion for the control of cardiovascular responses to extubation after intracranial surgery.
Lim SH; Chin NM; Tai HY; Wong M; Lin TK
Ann Acad Med Singap; 2000 Jul; 29(4):447-51. PubMed ID: 11056773
[TBL] [Abstract][Full Text] [Related]
37. Managing critically ill patients with esmolol. An ultra short-acting beta-adrenergic blocker.
Gray RJ
Chest; 1988 Feb; 93(2):398-403. PubMed ID: 2892647
[TBL] [Abstract][Full Text] [Related]
38. Comparison of efficacy of intravenous diltiazem and esmolol in terminating supraventricular tachycardia.
Gupta A; Naik A; Vora A; Lokhandwala Y
J Assoc Physicians India; 1999 Oct; 47(10):969-72. PubMed ID: 10778689
[TBL] [Abstract][Full Text] [Related]
39. The use of esmolol in whole-body hyperthermia: cardiovascular effects.
Berry JM; Michalsen A; Nagle V; Bull JM
Int J Hyperthermia; 1997; 13(3):261-8. PubMed ID: 9222810
[TBL] [Abstract][Full Text] [Related]
40. Esmolol. A review of its therapeutic efficacy and pharmacokinetic characteristics.
Wiest D
Clin Pharmacokinet; 1995 Mar; 28(3):190-202. PubMed ID: 7758250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
